Pages that link to "Q33412940"

The following pages link to Chronic myelomonocytic leukaemia: a concise clinical and pathophysiological review (Q33412940):

Displaying 41 items.

• Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia (Q26768600) (← links)
• Extramedullary hematopoiesis in a sentinel lymph node as an early sign of chronic myelomonocytic leukemia (Q33422741) (← links)
• Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome (Q33600822) (← links)
• CEBPA-mediated upregulation of the lncRNA PLIN2 promotes the development of chronic myelogenous leukemia via the GSK3 and Wnt/β-catenin signaling pathways (Q33732992) (← links)
• Impact of TET2, SRSF2, ASXL1 and SETBP1 mutations on survival of patients with chronic myelomonocytic leukemia (Q35654081) (← links)
• MiR-362-5p promotes the malignancy of chronic myelocytic leukaemia via down-regulation of GADD45α. (Q36259116) (← links)
• Prognostic interaction between ASXL1 and TET2 mutations in chronic myelomonocytic leukemia (Q36548070) (← links)
• An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms. (Q36708989) (← links)
• Chronic myelomonocytic leukemia: Forefront of the field in 2015. (Q36876853) (← links)
• TET2 mutations were predictive of inferior prognosis in the presence of ASXL1 mutations in patients with chronic myelomonocytic leukemia (Q37345073) (← links)
• Clinical management of myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes (Q37349392) (← links)
• Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic features (Q37636744) (← links)
• Chronic Myelomonocytic Leukemia: a Genetic and Clinical Update. (Q38540013) (← links)
• Principles of analytical validation of next-generation sequencing based mutational analysis for hematologic neoplasms in a CLIA-certified laboratory. (Q38696183) (← links)
• Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms. (Q38722106) (← links)
• Chronic myelomonocytic leukemia: 2016 update on diagnosis, risk stratification, and management (Q38835771) (← links)
• Primary myelofibrosis: 2017 update on diagnosis, risk-stratification, and management (Q39015300) (← links)
• The Corepressor Rcor1 Is Essential for Normal Myeloerythroid Lineage Differentiation (Q40788149) (← links)
• A novel del(8)(q23.2q24.11) contributing to disease progression in a case of JAK2/TET2 double mutated chronic myelomonocytic leukemia (Q41779710) (← links)
• Unusual lower back pain with monocytosis: A case report (Q42370517) (← links)
• Chronic myelomonocytic leukemia as a cause of fatal uncontrolled inflammation in familial Mediterranean fever (Q42386239) (← links)
• ASXL1 mutated chronic myelomonocytic leukemia in a patient with familial thrombocytopenia secondary to germline mutation in ANKRD26. (Q42413857) (← links)
• Auer Rods in Chronic Myelomonocytic Leukemia Can Change the Diagnosis (Q43068468) (← links)
• SETBP1 mutations as a biomarker for myelodysplasia /myeloproliferative neoplasm overlap syndrome (Q47140333) (← links)
• Primary myelofibrosis: 2014 update on diagnosis, risk-stratification, and management (Q50462637) (← links)
• Myelodysplastic/myeloproliferative neoplasms: a disease in need of recognition (Q50891297) (← links)
• A case of chronic myelomonocytic leukemia complicated with spondyloarthritis (Q50981280) (← links)
• Blast transformation in chronic myelomonocytic leukemia: Risk factors, genetic features, survival, and treatment outcome (Q51060167) (← links)
• Acquired expression of CblQ367P in mice induces dysplastic myelopoiesis mimicking chronic myelomonocytic leukemia (Q51134421) (← links)
• ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients. (Q53059564) (← links)
• Molecular and prognostic correlates of cytogenetic abnormalities in chronic myelomonocytic leukemia: a Mayo Clinic-French Consortium Study. (Q53084501) (← links)
• [Diagnostic molecular pathology of lymphatic and myeloid neoplasms]. (Q53569851) (← links)
• Serotonin receptor type 1B constitutes a therapeutic target for MDS and CMML (Q58733645) (← links)
• NUP98-HBO1-fusion generates phenotypically and genetically relevant chronic myelomonocytic leukemia pathogenesis (Q64078767) (← links)
• Utx loss causes myeloid transformation (Q87873955) (← links)
• Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and management (Q89023415) (← links)
• MicroRNA-141-5p Acts as a Tumor Suppressor via Targeting RAB32 in Chronic Myeloid Leukemia (Q89619891) (← links)
• Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions (Q91709967) (← links)
• The Austrian biodatabase for chronic myelomonocytic leukemia (ABCMML) : A representative and useful real-life data source for further biomedical research (Q92009832) (← links)
• MiR-659-3p regulates the progression of chronic myeloid leukemia by targeting SPHK1 (Q92646188) (← links)
• Transformation of CMML to AML presenting with acute kidney injury (Q98770714) (← links)